Back

Lipoprotein(a) measurements identify patients with elevated likelihood of obstructive coronary artery disease despite very low or low clinical likelihood

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (3) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Gitte Stokvad Brix

Goedstrup Hospital, Herning (Denmark)

5 More presentations in this session

Presentation thumbnail
Influence of the non-lipoprotein(a) apolipoprotein B/lipoprotein(a) ratio and other risk factors on coronary arterial aterosclerotic burden in acute coronary syndrome.
Doctor A. Meseguer Hernandez (Cartagena, ES)
Abstract Slides Video
Presentation thumbnail
High-sensitive CRP is a reliable biomarker for predicting events in a cardiovascular population
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Age and risk scores for detecting coronary artery calcification in heterozygous familial hypercholesterolemia
Mr O. Decanini Cantarella Silva (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Risk of cardiovascular events in U.S. patients using the SMART risk score
Doctor D. Fernandez Vazquez (Lorca, ES)
Abstract Slides Video
Presentation thumbnail
A 4-protein biomarker risk score enhances cardiovascular risk assessment: insights from the multi-ethnic study of atherosclerosis
Assistant Professor J. Medina-Inojosa (Atlanta, US)
Abstract Slides

Access the full session

Session thumbnail
Risk factors (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Relation of Lp(a) with plaque characteristics and clinical events: ATHEROREMO and IBIS_3 cohorts
thumbnail
Congress Presentation
Lipoprotein(a) levels in acute coronary syndrome: analysis of sex, age, and cardiovascular risk factors
thumbnail
Congress Presentation
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: design, rationale, and first results of the Zabrze-Lip(a)R Registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources